AstraZeneca PLC - American Depositary Shares (NY:AZN)

182.61 +0.09 (+0.05%)

Streaming Delayed Price Updated: 12:56 PM EDT, May 8, 2026 Add to My Watchlist

Price and Volume

Volume	676,465
Open	182.71
Bid (Size)	182.55 (300)
Ask (Size)	182.68 (200)
Prev. Close	182.52
Today's Range	181.58 - 183.55
52wk Range	180.00 - 212.71
Shares Outstanding	N/A
Dividend Yield	0.51%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

This Low-Cost ETF Holds Almost 8,800 Stocks Across Both Developed and Emerging Markets. Here's Why It's a Compelling Long-Term Core Holding ↗

May 07, 2026

If you're looking for diversification and value, here's a good ETF to check out.

Via The Motley Fool

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat ↗

May 02, 2026

Via MarketBeat

Performance

YTD	-3.1%	-3.1%
1 Month	-9.1%	-9.1%
3 Month	-2.4%	-2.4%
6 Month	-3.1%	-3.1%
1 Year	-3.1%	-3.1%

More News

TRUQAP® (capivasertib) recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer

April 30, 2026

From AstraZeneca

Via Business Wire

AstraZeneca results: Q1 2026

April 29, 2026

From AstraZeneca

Via Business Wire

AstraZeneca (NYSE:AZN) Passes the Caviar Cruise Quality Screen with Strong Profitability and Growth ↗

April 24, 2026

Via Chartmill

BREZTRI approved in the US for asthma as first and only triple therapy for patients 12 years of age and older

April 28, 2026

From AstraZeneca

Via Business Wire

SAPHNELO approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus

April 27, 2026

From AstraZeneca

Via Business Wire

Is Bristol Myers Squibb the Best Bargain in Big Pharma? ↗

April 27, 2026

Via The Motley Fool

Pictet Loads Up MercadoLibre With 3,500 Shares Worth $6.8 Million ↗

April 14, 2026

Via The Motley Fool

Could AbbVie Crash Lilly's Weight‑Loss Party? ↗

April 14, 2026

Via The Motley Fool

Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity

April 13, 2026

Via MarketMinute

Gilead Sciences Solidifies Oncology Future with $5 Billion Acquisition of ADC Innovator Tubulis

April 09, 2026

Via MarketMinute

Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring

April 03, 2026

Via MarketMinute

Merck’s Oncology Empire Expands: Keytruda Secures Pivotal European Commission Approval for Recurrent Ovarian Cancer

April 02, 2026

Via MarketMinute

IMFINZI® (durvalumab) + IMJUDO® (tremelimumab-actl) improves PFS in early liver cancer

April 02, 2026

From AstraZeneca

Via Business Wire

Corcept Therapeutics Outperforms: How a Surprise FDA Approval Ignited a Late-March Rally

March 31, 2026

Via MarketMinute

Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability

March 31, 2026

Via Finterra

AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results

March 27, 2026

Via MarketMinute

Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD

March 27, 2026

From AstraZeneca

Via Business Wire

Merck & Co. (MRK) 2026 Analysis: Navigating the Keytruda Cliff with Pipeline-Driven Resilience

March 25, 2026

Via Finterra

The Great Unbundling: How AI’s Insatiable Hunger is Driving a Corporate Divestiture Gold Rush

March 18, 2026

Via MarketMinute

Could This International ETF Be One of the Best Investments of 2026? ↗

March 14, 2026

Via The Motley Fool

The 'Sentiment Trap': Why Beating Earnings Is No Longer Enough in the Age of AI Sentiment Analysis

March 13, 2026

Via MarketMinute

The Billion-Dollar Divide: How "Megadeals" Are Defining a K-Shaped M&A Market in 2026

March 11, 2026

Via MarketMinute

Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity

March 10, 2026

Via Finterra

Frequently Asked Questions

Is AstraZeneca PLC - American Depositary Shares publicly traded?

Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.

What exchange does AstraZeneca PLC - American Depositary Shares trade on?

AstraZeneca PLC - American Depositary Shares trades on the New York Stock Exchange

What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?

The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the New York Stock Exchange

What is the current price of AstraZeneca PLC - American Depositary Shares?

The current price of AstraZeneca PLC - American Depositary Shares is 182.61

When was AstraZeneca PLC - American Depositary Shares last traded?

The last trade of AstraZeneca PLC - American Depositary Shares was at 05/08/26 12:56 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.